Clinically isolated laryngeal sarcoidosis

Christina Caroline Plaschke, Niels Rasmussen, Hanne Højris Owen

23 Citationer (Scopus)


Laryngeal sarcoidosis is rare (0.5% of patients with sarcoidosis), the pathogenesis is unknown and the optimal treatment remains a matter of debate. We undertook this study to elucidate possible pathogenic factors in clinically isolated laryngeal sarcoidosis and to describe results of supraglottoplastic surgery. From 1995 to 2009, we identified six patients with histologically proven sarcoidosis of the larynx treated at Rigshospitalet. All patients were subjected to a panel of blood tests and MR scan of the head and neck. All patients had dyspnoea at admission, and five were subjected to a combination of CO(2)-laser excision of supraglottic tissue and closure of the incision with sutures. All serological tests were negative or normal, including angiotensin 1 converting enzyme. The clinical expression was uniform with pale, smooth swellings of the supraglottic structures. Surgery proved successful to maintain normal breathing. None of the many parameters examined--some previously having been found to be abnormal in sarcoidosis--were abnormal in the present cohort. We are therefore unable to elucidate the pathogenesis. The combined surgical approach re-established normal airway function for all five patients and complete remission without further swellings was seen in two patients.
TidsskriftEuropean Archives of Oto-Rhino-Laryngology
Udgave nummer4
Sider (fra-til)575-80
Antal sider6
StatusUdgivet - 2011


Dyk ned i forskningsemnerne om 'Clinically isolated laryngeal sarcoidosis'. Sammen danner de et unikt fingeraftryk.